2.65
Indaptus Therapeutics Inc Aktie (INDP) Neueste Nachrichten
What Does the Market Think About Indaptus Therapeutics Inc? - Benzinga
Indaptus Therapeutics Inc. (INDP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Indaptus Therapeutics Inc.: Are They Ready for Takeoff? - StocksToTrade
Biotech Stocks To Keep An Eye OnDecember 24th - MarketBeat
Indaptus Therapeutics, Inc.Common Stock (Nasdaq:INDP) Stock Quote - FinancialContent
Is It Too Late to Buy INDP Stock? - timothysykes.com
Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question - ts2.tech
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading? - Benzinga
Indaptus Therapeutics, Uipath, Trinity Biotech, Sable Offshore And McDonald's: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Indaptus Therapeutics : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
Trending Stocks Today | Indaptus Therapeutics Soars 52.9% Post-Market - 富途牛牛
Indaptus Therapeutics Inc appoints David Lazar as co-chief executive officer - marketscreener.com
Indaptus Therapeutics Signs Securities Purchase Agreement With David Lazar - TradingView — Track All Markets
[8-K] Indaptus Therapeutics, Inc. Reports Material Event | INDP SEC FilingForm 8-K - Stock Titan
Indaptus Therapeutics, Inc. announced that it has received $6 million in funding - marketscreener.com
Indaptus Therapeutics, Inc. announced that it expects to receive $6 million in funding - marketscreener.com
Can Indaptus Therapeutics Inc. stock hit record highs again2025 Top Gainers & Precise Entry and Exit Recommendations - Улправда
How buybacks impact Indaptus Therapeutics Inc. stock valueTrade Analysis Summary & AI Forecast for Swing Trade Picks - Улправда
Breakout Move: Is Indaptus Therapeutics Inc stock attractive for hedge fundsJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - moha.gov.vn
Will Indaptus Therapeutics Inc. stock outperform value stocksShort Setup & Weekly High Potential Stock Alerts - DonanımHaber
How analysts rate Indaptus Therapeutics Inc. stock todayMarket Risk Report & Scalable Portfolio Growth Methods - Bölüm Sonu Canavarı
Is Indaptus Therapeutics Inc. stock a good choice for value investors2025 Valuation Update & Long Hold Capital Preservation Plans - ulpravda.ru
Published on: 2025-12-19 01:13:33 - moha.gov.vn
Indaptus Therapeutics Earnings Notes - Trefis
Indaptus Therapeutics (NASDAQ:INDP) Downgraded by Wall Street Zen to “Sell” - Defense World
Indaptus Therapeutics (NASDAQ:INDP) Rating Increased to Hold at Wall Street Zen - Defense World
Pullback Watch: How buybacks impact Indaptus Therapeutics Inc. stock valueMarket Weekly Review & Risk Controlled Stock Pick Alerts - moha.gov.vn
Nuvalent (NUVL) Receives a New Rating from Truist Financial - The Globe and Mail
Indaptus Therapeutics (INDP) Price Target Decreased by 60.00% to 10.20 - MSN
Volume spikes in Indaptus Therapeutics Inc. stock – what they meanEarnings Risk Summary & Smart Investment Allocation Insights - newser.com
Ranking Indaptus Therapeutics Inc. among high performing stocks via toolsTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
Why Indaptus Therapeutics Inc. stock could see breakout soonPortfolio Return Report & Low Volatility Stock Recommendations - newser.com
Will Indaptus Therapeutics Inc. rebound enough to break evenJuly 2025 Recap & Expert Approved Momentum Ideas - newser.com
How high can Indaptus Therapeutics Inc. stock go2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
What momentum indicators show for Indaptus Therapeutics Inc. stockMarket Sentiment Summary & Daily Profit Focused Screening - newser.com
Indaptus Therapeutics 3Q Research and Development Expenses About $1.52M >INDP - 富途牛牛
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit - The Manila Times
Why Is Indaptus Therapeutics, Inc. (INDP) Stock Down Today? - Meyka
Indaptus (Nasdaq: INDP) showcases Decoy20 to tackle donor cell variability - Stock Titan
Volatility clustering patterns for Indaptus Therapeutics Inc.Weekly Trade Analysis & Reliable Intraday Trade Alerts - newser.com
Does Indaptus Therapeutics Inc. fit your quant trading modelJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - newser.com
Why retail investors pile into Indaptus Therapeutics Inc. stockWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Can Indaptus Therapeutics Inc. stock double in next 5 yearsSwing Trade & Expert Curated Trade Setups - newser.com
Is Indaptus Therapeutics Inc. stock ready for a breakoutWeekly Stock Recap & Technical Buy Zone Confirmations - newser.com
Key resistance and support levels for Indaptus Therapeutics Inc.Weekly Profit Summary & Community Verified Watchlist Alerts - newser.com
Exit strategy if you’re trapped in Indaptus Therapeutics Inc.Weekly Volume Report & High Yield Equity Trading Tips - newser.com
Is Indaptus Therapeutics Inc. stock a defensive play in 2025Insider Buying & AI Forecasted Stock Moves - Fundação Cultural do Pará
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):